Patients Professionals Professional oportunities About Novo Nordisk Contact Spain Press room Novo Nordisk is a global healthcare company based in Denmark with over 90 years of innovation and leadership in diabetes care. The company also holds prominent positions in hemophilia care, growth hormone therapy, and hormone replacement therapy. Novo Nordisk is headquartered in Denmark. Press room onetwo34 Prev Next Novo Nordisk Spain Are you interested in knowing more about our history and way of working? Read more Contact Work at Novo Nordisk Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. The company also holds leadership positions in hemophilia care, growth hormone therapy, and hormone replacement therapy. Read more Meet the Novo Nordisk Way Our work at Novo Nordisk is guided by the Novo Nordisk Way. It describes who we are, where we want to go and how we want to work. It sets the direction for Novo Nordisk employees, no matter what they do or where they work. Read more To explore open positions Interested in a global career? Employment searcher Be the first one to know Follow us About us Con sede en Dinamarca, Novo Nordisk es una compañía global de cuidados sanitarios y más de 90 años de innovación y liderazgo en diabetes. La compañía también ostenta posiciones de liderazgo en el cuidado de la hemofilia y los trastornos del crecimiento. Novo Nordisk emplea aproximadamente a 41.500 personas en 75 países, y comercializa sus productos en más de 180 países. Páginas webs Novo Nordisk NovoNordisk.com O seleccionee: Otros Paises Otros sitios Novo Nordisk en el mundo Mapa, direcciones e información de ruta © 2015 Copyright Novo Nordisk Pharma, S.A. Aviso Legal

Patients Professionals Professional oportunities About Novo Nordisk Contact Spain Novo Nordisk Spain / Patients / Hemostasis Patients Diabetes Haemostasis Prospectuses Growth hormone Haemostasis Management of hemostasis Hemophilia is a congenital or acquired bleeding disorder caused by a deficiency of factor VIII coagulation (hemophilia A) or factor IX (hemophilia B). 85% of patients suffer from hemophilia A –or, in other words, factor VIII deficiency– and the remaining 15%, hemophilia B. It is estimated that, in Spain, some 3,000 people (in the world, 400,000) suffer hemophilia. Around 20% are under 20 years of age. About us Headquartered in Denmark, Novo Nordisk is a global healthcare company and over 90 years of innovation and leadership in diabetes. The company also holds leadership positions in the care of hemophilia and growth disorders. Novo Nordisk employs approximately 41,500 people in 75 countries, and markets its products in more than 180 countries. Novo Nordisk websites NovoNordisk.com Or select: Other countries Other places Novo Nordisk in the world Map, directions and route information © 2015 Copyright Novo Nordisk Pharma, SA Legal Notice